Health and Healthcare

Gilead Sciences : GILD

All Gilead Sciences Articles

732 Articles

Lee Jackson | Nov 13, 2014 at 9:15 AM EST

4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic

A new research report from the analysts at UBS focuses on four companies that stand to benefit from rising demand…

Jon C. Ogg | Nov 12, 2014 at 1:35 PM EST

Gilead Sees Large Insider Stock Sale Into Debt Offering

A Gilead Sciences bond offering and a key insider stock sale netting over $14 million should be considered by investors.

Chris Lange | Nov 12, 2014 at 8:40 AM EST

Biotech Short Interest Becomes Stock Specific (Updated)

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies, such as Ebola-vaccine companies.

Lee Jackson | Oct 30, 2014 at 8:55 AM EDT

Top Health Care and Biotech Stocks to Buy That Have Already Posted Earnings

A new research note from Cowen focuses on health care companies that have released earnings and offer investors reasons to…

Chris Lange | Oct 29, 2014 at 7:55 AM EDT

Gilead Sciences Earnings Miss on Dwindling Sovaldi Sales

Gilead Sciences reported disappointing third-quarter results after the market close on Monday.

Chris Lange | Oct 28, 2014 at 11:55 AM EDT

What to Look For in Gilead Sciences Earnings Report

Gilead Sciences is set to report its third-quarter earnings after the U.S. markets close on Tuesday.

Chris Lange | Oct 27, 2014 at 10:30 AM EDT

Biotech Short Interest Becomes Stock Specific

Short interest in biotech leaders changed from directional to stock specific in the first two weeks of October.

Lee Jackson | Oct 13, 2014 at 8:40 AM EDT

UBS Very Positive on Top Biotech Stocks Ahead of Earnings

Rising trends in prescriptions and higher, yet beatable increases in earnings have set the table for what the UBS biotech…

Lee Jackson | Oct 8, 2014 at 9:00 AM EDT

Deutsche Bank’s Top Stocks to Buy Now for This Quarter and 2015

In a new research report, Deutsche Bank analysts suggest investors focus on sectors like technology, health care, financials and selected…

Lee Jackson | Oct 2, 2014 at 9:50 AM EDT

Merrill Lynch’s Top Catalyst Ideas for the Fourth Quarter

A new research report from Merrill Lynch highlights 10 top catalyst-driven ideas for the fourth quarter.

Jon C. Ogg | Sep 25, 2014 at 10:50 AM EDT

Short Sellers Make Moves in Key Biotech Stocks

Short sellers are often active in biotech stocks, and we have seen some excessive short interest activity in the most…

Lee Jackson | Sep 15, 2014 at 10:55 AM EDT

U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks

A new research report from UBS focuses on four top companies that are making great strides in treatments for patients…

Chris Lange | Sep 11, 2014 at 9:20 AM EDT

Short Sellers Remain Vigilant Against Biotechs

Short sellers are often active in biotech stocks, and we have seen some excessive short interest activity in the latest…

Lee Jackson | Sep 9, 2014 at 8:30 AM EDT

Deutsche Bank’s 4 Top Biotech Stocks to Buy for This Year and 2015

A new report from the biotech team at Deutsche Bank fields questions from clients asking for specific stocks to buy…

Jon C. Ogg | Aug 15, 2014 at 8:18 AM EDT

Top Analyst Upgrades and Downgrades: Achillion, Monster, Gilead, JCPenney, JDSU, Green Mountain and More

Jon OggStocks were firm yet again on Friday morning ahead of the PPI wholesale inflation report. Investors have been trying…

1 … 34 35 36 37 38 … 49

Gilead Sciences : GILD

All Gilead Sciences Articles

4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic

Gilead Sees Large Insider Stock Sale Into Debt Offering

Biotech Short Interest Becomes Stock Specific (Updated)

Top Health Care and Biotech Stocks to Buy That Have Already Posted Earnings

Gilead Sciences Earnings Miss on Dwindling Sovaldi Sales

What to Look For in Gilead Sciences Earnings Report

Biotech Short Interest Becomes Stock Specific

UBS Very Positive on Top Biotech Stocks Ahead of Earnings

Deutsche Bank’s Top Stocks to Buy Now for This Quarter and 2015

Merrill Lynch’s Top Catalyst Ideas for the Fourth Quarter

Short Sellers Make Moves in Key Biotech Stocks

U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks

Short Sellers Remain Vigilant Against Biotechs

Deutsche Bank’s 4 Top Biotech Stocks to Buy for This Year and 2015

Top Analyst Upgrades and Downgrades: Achillion, Monster, Gilead, JCPenney, JDSU, Green Mountain and More

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

Gilead Sciences : GILD

All Gilead Sciences Articles

4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic

Gilead Sees Large Insider Stock Sale Into Debt Offering

Biotech Short Interest Becomes Stock Specific (Updated)

Top Health Care and Biotech Stocks to Buy That Have Already Posted Earnings

Gilead Sciences Earnings Miss on Dwindling Sovaldi Sales

What to Look For in Gilead Sciences Earnings Report

Biotech Short Interest Becomes Stock Specific

UBS Very Positive on Top Biotech Stocks Ahead of Earnings

Deutsche Bank’s Top Stocks to Buy Now for This Quarter and 2015

Merrill Lynch’s Top Catalyst Ideas for the Fourth Quarter

Short Sellers Make Moves in Key Biotech Stocks

U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks

Short Sellers Remain Vigilant Against Biotechs

Deutsche Bank’s 4 Top Biotech Stocks to Buy for This Year and 2015

Top Analyst Upgrades and Downgrades: Achillion, Monster, Gilead, JCPenney, JDSU, Green Mountain and More

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

Featured Reads

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings